Nursing Elites

1. A nurse is reviewing the medication record of a client with chronic kidney disease. Which of the following medications should the nurse question?

• A. Calcium carbonate
• B. Furosemide
• C. Epoetin alfa
• D. Spironolactone

Correct answer: D

Rationale: The correct answer is D, Spironolactone. Spironolactone is a potassium-sparing diuretic, which may lead to hyperkalemia in clients with chronic kidney disease. Therefore, its use should be questioned in this population. Choice A, Calcium carbonate, is commonly used to manage phosphate levels in chronic kidney disease. Choice B, Furosemide, is a loop diuretic that helps with fluid retention but should be used with caution in kidney disease. Choice C, Epoetin alfa, is a medication used to stimulate red blood cell production in clients with chronic kidney disease and anemia.

2. A client who has a new prescription for levothyroxine is receiving teaching from a nurse. Which statement by the client indicates an understanding of the teaching?

• A. I will need to take this medication for 3 months.
• B. I will take this medication with an antacid.
• C. I will avoid foods that contain iodine.
• D. I will take this medication in the morning before breakfast.

Correct answer: D

Rationale: The correct answer is D: "I will take this medication in the morning before breakfast." Levothyroxine should be taken in the morning before breakfast to improve absorption and effectiveness. Choice A is incorrect because the duration of levothyroxine therapy is usually long-term and not limited to 3 months. Choice B is incorrect because levothyroxine should not be taken with antacids as they may decrease its absorption. Choice C is incorrect because there is no need to avoid foods that contain iodine while taking levothyroxine.

3. A nurse is providing teaching to a client who has a new diagnosis of osteoporosis and is prescribed alendronate. Which of the following instructions should the nurse include?

• A. Take this medication with food.
• B. Take this medication with a full glass of water after meals.
• C. Take this medication on an empty stomach with a full glass of water.
• D. You can take this medication at any time of day.

Correct answer: C

Rationale: Correct Answer: C. Alendronate should be taken on an empty stomach with a full glass of water to ensure proper absorption. Choice A is incorrect because alendronate should not be taken with food. Choice B is incorrect because alendronate should be taken on an empty stomach, not after meals. Choice D is incorrect because alendronate should be taken at a specific time following the instructions given.

4. Which medication is commonly prescribed for patients with atrial fibrillation?

• A. Warfarin
• B. Digoxin
• C. Aspirin
• D. Lisinopril

Correct answer: B

Rationale: Digoxin is commonly prescribed to manage atrial fibrillation by controlling heart rate. While Warfarin is used to prevent blood clots, it is not primarily used for controlling heart rate in atrial fibrillation. Aspirin is not the first-line treatment for atrial fibrillation and is generally not recommended for rhythm control. Lisinopril is an ACE inhibitor used to treat high blood pressure and heart failure, but it is not typically prescribed as the primary medication for managing atrial fibrillation.

5. How should a healthcare provider monitor a patient receiving heparin therapy?

• A. Monitor aPTT
• B. Monitor platelet count
• C. Monitor sodium levels
• D. Monitor calcium levels

Correct answer: A

Rationale: The correct answer is to monitor aPTT (activated partial thromboplastin time) when a patient is receiving heparin therapy. aPTT monitoring is essential for assessing the therapeutic effectiveness of heparin, ensuring the patient is within the desired therapeutic range to prevent both clotting and bleeding. Monitoring platelet count (Choice B) is important for assessing for heparin-induced thrombocytopenia but is not the primary monitoring parameter for heparin therapy. Monitoring sodium levels (Choice C) and calcium levels (Choice D) are not directly related to assessing the therapeutic effectiveness or potential side effects of heparin therapy.

Similar Questions